Tafnat Tablet

Aperçu du produit

About Tafnat Tablet

Tafnat Tablet is a medication containing the active ingredient Tenofovir Alafenamide, classified as Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor. 1 INDICATIONS AND USAGE BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are.

Key Benefits & Uses

• Used for: 1 INDICATIONS AND USAGE BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in.
• Use only as directed on the product label or by a healthcare professional.
• Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Tenofovir Alafenamide, the active ingredient in Tafnat Tablet, belongs to the Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor class. 1 INDICATIONS AND USAGE BIKTARVY is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg: who have no antiretroviral treatment history or to replace the current antiretroviral regimen in those who are. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking Tafnat Tablet. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use Tafnat Tablet for extended periods without medical advice.